1,3-dipropyl-8-cyclopentylxanthine has been researched along with Encephalopathy, Toxic in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cognato, GP | 1 |
| Agostinho, PM | 1 |
| Hockemeyer, J | 1 |
| Müller, CE | 1 |
| Souza, DO | 1 |
| Cunha, RA | 1 |
| Butler, TR | 1 |
| Smith, KJ | 1 |
| Self, RL | 1 |
| Braden, BB | 1 |
| Prendergast, MA | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Encephalopathy, Toxic
| Article | Year |
|---|---|
Caffeine and an adenosine A(2A) receptor antagonist prevent memory impairment and synaptotoxicity in adult rats triggered by a convulsive episode in early life.
Topics: Adenosine A2 Receptor Antagonists; Analysis of Variance; Animals; Animals, Newborn; Caffeine; Diseas | 2010 |
Sex differences in the neurotoxic effects of adenosine A1 receptor antagonism during ethanol withdrawal: reversal with an A1 receptor agonist or an NMDA receptor antagonist.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Animals; Cell Survival | 2008 |